Building Transplant Programs
Bill Frist and Peter Attia discuss the process of building transplant programs, including the challenges they faced and the importance of designated centers of excellence. They also touch on the resistance from insurance companies and the significance of Medicare's reimbursement system.In this clip
From this podcast
The Peter Attia Drive Podcast
#150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business
Related Questions
I would love to hear your thoughts on liver transplants, specifically in the case of my daughter. She had a liver transplant 11 years ago due to biliary atresia and has been doing amazingly well since then—without any issues or rejections. Her doctors call her the poster child for liver transplants, and her labs are all perfect. The only medication she is on is an anti-rejection med, tacrolimus.
I would love to hear your thoughts on liver transplants, particularly in the case of my daughter. She had a liver transplant 11 years ago due to biliary atresia and has been doing amazingly well since then—without any issues or rejections. Her doctors call her the poster child for liver transplants, and her labs are all perfect. The only medication she is on is an anti-rejection med, tacrolimus.
I have a question about episode #150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business and the clip Medical Breakthroughs. I would love to hear your thoughts on liver transplants, specifically in the case of my daughter who had a liver transplant 11 years ago due to biliary atresia and has been doing amazingly well since then—without any issues or rejections. Her doctors call her the poster child for liver transplants, and her labs are all perfect. The only medication she is on is an anti-rejection medication, tacrolimus.